Is Black Hawk Acquisition going out of business?

Black Hawk Acquisition Corp (BKHA) Fundamentals

A quick summary of the latest filed figures while the full analysis loads.

Black Hawk Acquisition Corp (BKHA) fundamentals, assembled from SEC filings.

Five questions, kept separate

Survival - Critical

Under 1 mo of estimated runway from 2026-05-31, based on $0.0 of cash and short-term investments against $1.1M of annual burn.

Business quality - Pre-commercial

Operating margins cannot grade a pipeline; Survival and clinical evidence remain the relevant lenses here.

Trajectory - Clinical progress unavailable

Fundamentals can show funding and burn, but not whether the clinical pipeline is advancing.

Valuation - Evidence incomplete

A positive current market capitalization is unavailable, so price-to-fundamentals evidence cannot be computed.

Event risk - Critical event risk

Going-Concern Warning is the decisive filing event; one adverse event family is active. It appears across 2 scanned filings. Favorable events are shown separately and do not offset adverse risk.

What the rules read

• Interest coverage: -8.2x
• Filing event risk: Going-Concern Warning (-8 pts)
• Cash Runway (years): Self-funded
• Return on Assets: 5.24%
• Price / Earnings: Unprofitable (see Valuation)

Read from filings through 2026-08-26.

Price as of 2026-09-09.